Author Contributions Concept and design: Ibaadat Kahlon, Simone Sekhon , William Latson Acquisition, analysis, or interpretation of data: Ibaadat Kahlon, William Latson Drafting of the manuscript: Ibaadat Kahlon, Simone Sekhon , William Latson Critical review of the manuscript for important intellectual content: Ibaadat Kahlon, Simone Sekhon , William Latson Supervision: William Latson References 1.A new drug for obesity: tirzepatide
In addition, whether GSH deficiency is the prime mode of the pro-oxidant actions of the GCL/GSS/glutamyl-amino acid transporter inhibitor, L-buthionine sulfoximine 4 needs to be revisited
In aortic aneurysm, degradation products of the glycocalyx, syndecans, may serve as biomarkers and therapeutic targets (35)
They will also emphasize the importance of lifestyle modifications, such as adopting a healthy diet and increasing physical activity